ClinVar Miner

Submissions for variant NM_000179.2(MSH6):c.2653A>T (p.Lys885Ter) (rs587782593)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000131937 SCV000186993 pathogenic Hereditary cancer-predisposing syndrome 2016-11-30 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Alterations resulting in premature truncation (e.g.reading frame shift, nonsense)
GeneDx RCV000578967 SCV000680903 pathogenic not provided 2018-01-26 criteria provided, single submitter clinical testing The K885X variant in the MSH6 gene has been reported previously in an individual with breast cancer (Tedaldi et al, 2017). The International Society for Gastroinestinal Hereditary Tumors Incorporated (InSiGHT) classifies this variant as pathogenic (Thompson et al., 2014). The K885X variant is not observed in large population cohorts (Lek et al., 2016). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Loss-of-function variants are known to be pathogenic in this gene associated with Lynch syndrome. Based on the ACMG recommendations, K885X is interpreted as a known pathogenic sequence change.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.